New training module for patient representatives in Sweden on the HTA regulation released

The module was developed by SBU in collaboration with EUPATI Sweden and is primarily intended for patient representatives who would like to participate in HTAR activities.

The Health Technology Assessment Regulation (HTAR) requires EU Member States to carry out joint clinical assessments (JCAs) of new medicines and certain high-risk medical devices. One of its main aims is to reduce duplication of work across Europe by ensuring that the same health technologies do not need to be assessed separately in multiple countries.

Although primarily aimed at patient representatives, the training (in Swedish) is open to anyone interested in learning more about HTAR. The module focuses on the JCA process, including how patients can contribute to Sweden's PICO, the assessment question that forms the basis of the evaluation.

Learn more about SBU and the HTAR regulation.